HOSPIRA Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HOSPIRA, and what generic alternatives to HOSPIRA drugs are available?
HOSPIRA has five hundred and eighteen approved drugs.
There are nine US patents protecting HOSPIRA drugs. There are seven tentative approvals on HOSPIRA drugs.
There are sixty-nine patent family members on HOSPIRA drugs in thirty-eight countries and four hundred and nineteen supplementary protection certificates in sixteen countries.
Summary for HOSPIRA
International Patents: | 69 |
US Patents: | 9 |
Tradenames: | 333 |
Ingredients: | 210 |
NDAs: | 518 |
Patent Litigation for HOSPIRA: | See patent lawsuits for HOSPIRA |
PTAB Cases with HOSPIRA as petitioner: | See PTAB cases with HOSPIRA as petitioner |
Drugs and US Patents for HOSPIRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hospira | RITODRINE HYDROCHLORIDE | ritodrine hydrochloride | INJECTABLE;INJECTION | 071619-001 | Feb 28, 1991 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hospira | CALCITRIOL | calcitriol | INJECTABLE;INJECTION | 075816-001 | Jan 16, 2004 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Hospira | DIAZEPAM | diazepam | INJECTABLE;INJECTION | 072079-001 | Dec 20, 1988 | AP | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for HOSPIRA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hospira | BRETYLOL | bretylium tosylate | INJECTABLE;INJECTION | 017954-001 | Approved Prior to Jan 1, 1982 | RE29618 | ⤷ Try a Trial |
Hospira | PRECEDEX | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 021038-002 | Mar 13, 2013 | 4,910,214*PED | ⤷ Try a Trial |
Hospira | PRECEDEX | dexmedetomidine hydrochloride | INJECTABLE;INJECTION | 021038-001 | Dec 17, 1999 | 5,344,840 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for HOSPIRA drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Injection | 100 mcg/mL | ➤ Subscribe | 2009-04-08 |
➤ Subscribe | Injection | 4 mcg/mL, 20 mL vials | ➤ Subscribe | 2015-09-30 |
➤ Subscribe | Injection | 1 mg/mL, 50 mL vials | ➤ Subscribe | 2011-12-16 |
➤ Subscribe | Injection | 4 mcg/mL, 50 mL and 100 mL vials | ➤ Subscribe | 2013-12-26 |
➤ Subscribe | Injection | 100 mg/mL, 2.5 mL vials | ➤ Subscribe | 2007-09-24 |
International Patents for HOSPIRA Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Colombia | 6680698 | ⤷ Try a Trial |
New Zealand | 607555 | ⤷ Try a Trial |
Japan | 5927680 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for HOSPIRA Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1912999 | 14C0076 | France | ⤷ Try a Trial | PRODUCT NAME: SIMEPREVIR OU L'UN DE SES SELS, INCLUANT LE SEL DE SODIUM DE SIMEPREVIR; REGISTRATION NO/DATE: EU/1/14/924 20140516 |
0717738 | 12/2002 | Austria | ⤷ Try a Trial | PRODUCT NAME: LINEZOLID; NAT. REGISTRATION NO/DATE: 1-24227 - 1-24230 20011009; FIRST REGISTRATION: GB PL 00032/0259 - PL 00032/0262 20010105 |
0961612 | 09C0050 | France | ⤷ Try a Trial | PRODUCT NAME: PACLITAXEL ALBUMINE; REGISTRATION NO/DATE: EU/1/07/428/001 20080111 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.